111 related articles for article (PubMed ID: 2835557)
1. Alloantibodies, autoantibodies, and immune complexes in patients with lung cancer.
Górny MK; Lawniczak M; Jenek R; Słowik-Gabryelska A; Kaczmarek E; Zeromski J
Lung; 1988; 166(2):97-105. PubMed ID: 2835557
[TBL] [Abstract][Full Text] [Related]
2. Anti-elastin antibodies in patients with lung cancer.
Gmiński J; Mykała-Cieśla J; Machalski M; Drózdz M
Immunol Lett; 1992 Jul; 33(2):211-5. PubMed ID: 1332926
[TBL] [Abstract][Full Text] [Related]
3. Incidence of alloantibodies and immune complexes in bronchial secretions of lung cancer patients.
Górny MK; Lawniczak M; Skrzypczak A; Zeromski J
Neoplasma; 1987; 34(2):189-98. PubMed ID: 3600884
[TBL] [Abstract][Full Text] [Related]
4. Pathological significance of circulating IgG anti-IgE complexes.
Paganelli R; Quinti I
Monogr Allergy; 1989; 26():184-97. PubMed ID: 2788813
[No Abstract] [Full Text] [Related]
5. Measurement and evaluation of serum anti-p53 antibody levels in patients with lung cancer at its initial presentation: a prospective study.
Segawa Y; Kageyama M; Suzuki S; Jinno K; Takigawa N; Fujimoto N; Hotta K; Eguchi K
Br J Cancer; 1998 Sep; 78(5):667-72. PubMed ID: 9744508
[TBL] [Abstract][Full Text] [Related]
6. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.
Winter SF; Minna JD; Johnson BE; Takahashi T; Gazdar AF; Carbone DP
Cancer Res; 1992 Aug; 52(15):4168-74. PubMed ID: 1322237
[TBL] [Abstract][Full Text] [Related]
7. [Experimental induction of immunity by anti-idiotypic vaccines against small-cell-lung cancer].
Li Y; Hu JY; Zhang Y; Zhu MJ; Zhao XT
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):269-72. PubMed ID: 15996316
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies against the Hel-N1 RNA-binding protein among patients with lung carcinoma: an association with type I anti-neuronal nuclear antibodies.
Dropcho EJ; King PH
Ann Neurol; 1994 Aug; 36(2):200-5. PubMed ID: 8053656
[TBL] [Abstract][Full Text] [Related]
9. A highly sensitive particle agglutination assay for the detection of P53 autoantibodies in patients with lung cancer.
Agaylan A; Binder D; Sauer M; Neuweiler H; Meyer O; Kiesewetter H; Salama A
Cancer; 2007 Dec; 110(11):2502-6. PubMed ID: 17932907
[TBL] [Abstract][Full Text] [Related]
10. [Detection and characterization of antigen component of circulating immune complex in sera from patients with lung cancer by monoclonal and polyclonal antibodies].
Xue W; Hou J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Apr; 13(2):96-100. PubMed ID: 1652382
[TBL] [Abstract][Full Text] [Related]
11. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer.
Brichory FM; Misek DE; Yim AM; Krause MC; Giordano TJ; Beer DG; Hanash SM
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9824-9. PubMed ID: 11504947
[TBL] [Abstract][Full Text] [Related]
12. Anti-idiotypic antibodies to anti-PDC-E2 in primary biliary cirrhosis and normal subjects.
Chen QY; Rowley MJ; Mackay IR
Hepatology; 1999 Mar; 29(3):624-31. PubMed ID: 10051459
[TBL] [Abstract][Full Text] [Related]
13. Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer?
Liu L; Liu N; Liu B; Yang Y; Zhang Q; Zhang W; Yu P; Jin Y; Guo J; Guan S; Sun S; Miao L; Wei J
J Cancer Res Clin Oncol; 2012 Oct; 138(10):1737-42. PubMed ID: 22699933
[TBL] [Abstract][Full Text] [Related]
14. Fine tuning of epitopic dominance induced by lung cancer on the IgG response to bovine betalactoglobulin: towards a paraneoplastic immune marker.
Michils A; Lambert JP; Yernault JC; Fabry V; Gossart B; Duchateau J
Cancer; 1996 Feb; 77(4):657-64. PubMed ID: 8616757
[TBL] [Abstract][Full Text] [Related]
15. Circulating immune complexes and autoantibodies in lung cancer.
Guy K; Di Mario U; Irvine WJ; Hunter AM; Hadley A; Horne NW
Br J Cancer; 1981 Mar; 43(3):276-83. PubMed ID: 7225280
[TBL] [Abstract][Full Text] [Related]
16. IgE/anti-IgE immune complexes in sera from patients with Crohn's disease do not contain food-specific IgE.
Huber A; Genser D; Spitzauer S; Scheiner O; Jensen-Jarolim E
Int Arch Allergy Immunol; 1998 Jan; 115(1):67-72. PubMed ID: 9430498
[TBL] [Abstract][Full Text] [Related]
17. The C1q binding test for soluble immune complexes: clinical correlations obtained in patients with cancer.
Rossen RD; Reisberg MA; Hersh EM; Gutterman JU
J Natl Cancer Inst; 1977 May; 58(5):1205-15. PubMed ID: 323505
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of different methods for detecting circulating immune complexes. Studies in patients with lung cancer.
Füst G; Fekete B; Angyal I; Jakab A; Pál A; Merétey K; Falus A; Török K; Szegedi G; Kávai M; Puskás E; Csécsi-Nagy M; Szabó T; Lenkey A; Misz M
J Immunol Methods; 1981; 46(3):259-76. PubMed ID: 6975788
[TBL] [Abstract][Full Text] [Related]
19. Detection of autoantibodies to livin and survivin in Sera from lung cancer patients.
Yagihashi A; Asanuma K; Kobayashi D; Tsuji N; Shijubo Y; Abe S; Hirohashi Y; Torigoe T; Sato N; Watanabe N
Lung Cancer; 2005 May; 48(2):217-21. PubMed ID: 15829321
[TBL] [Abstract][Full Text] [Related]
20. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus.
Antes U; Heinz HP; Loos M
Arthritis Rheum; 1988 Apr; 31(4):457-64. PubMed ID: 3258749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
